
Sarmustine
CAS No. 81965-43-7
Sarmustine( —— )
Catalog No. M34409 CAS No. 81965-43-7
Sarmustine (SarCNU) is an alkylating agent with anticancer activity that inhibits the growth of prostate cancer cells via p53-dependent and p53-independent pathways.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 296 | Get Quote |
![]() ![]() |
5MG | 459 | Get Quote |
![]() ![]() |
10MG | 657 | Get Quote |
![]() ![]() |
25MG | 994 | Get Quote |
![]() ![]() |
50MG | 1371 | Get Quote |
![]() ![]() |
100MG | 1773 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSarmustine
-
NoteResearch use only, not for human use.
-
Brief DescriptionSarmustine (SarCNU) is an alkylating agent with anticancer activity that inhibits the growth of prostate cancer cells via p53-dependent and p53-independent pathways.
-
DescriptionSarmustine (SarCNU) is an alkylating agent with anticancer activity that inhibits the growth of prostate cancer cells via p53-dependent and p53-independent pathways.Sarmustine mediates the selection of P140K methylguanine-DNA-methyltransferase-transduced human CD34(+) cells in vitro.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA Methyltransferase | p53 | DNA Alkylation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number81965-43-7
-
Formula Weight222.63
-
Molecular FormulaC6H11ClN4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N(CCCl)N=O)(N(CC(N)=O)C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
5-DTTP Na3
Deoxythymidine-5'-triphosphate (dTTP) trisodium salt is one of the four natural deoxynucleotides. It is used for the biosynthesis of deoxyribonucleic acid by DNA polymerase and reverse transcriptase.
-
G150
G150 inhibited interferon expression triggered by DSDNA with IC50 of 10.2 nM.
-
Pifithrin-μ
Pifithrin-μ is an inhibitor of p53 and HSP70, with neuroprotective and antitumor activity.